Loading…
Everolimus Eluting Stent Shows Better Patency with Reduced ISR Development for a Period of 2.4 years in Bangladeshi Stent Era: Our Experiences in Apollo Hospitals Dhaka
[...]long term data on In-stent re-stenosis (ISR) in these patients is not yet available. [...]the aim of our present study was to assess long-term outcome of stent patency or the development of ISR of varieties stent in single vessel territory. Among the DES, Everolimus Eluting stents shows better...
Saved in:
Published in: | The American journal of cardiology 2013-04, Vol.111 (7), p.77B-78B |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]long term data on In-stent re-stenosis (ISR) in these patients is not yet available. [...]the aim of our present study was to assess long-term outcome of stent patency or the development of ISR of varieties stent in single vessel territory. Among the DES, Everolimus Eluting stents shows better patency with reduced ISR than Paclitaxel and other limus eluting stent in this prospective cohort of Bangladeshi stent era for an average period of 2.4 yrs. |
---|---|
ISSN: | 0002-9149 1879-1913 |
DOI: | 10.1016/j.amjcard.2013.01.195 |